| Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer DG McNeel, EJ Dunphy, JG Davies, TP Frye, LE Johnson, MJ Staab, ... Journal of Clinical Oncology 27 (25), 4047-4054, 2009 | 278 | 2009 |
| Magnetic resonance imaging-transrectal ultrasound guided fusion biopsy to detect progression in patients with existing lesions on active surveillance for low and intermediate … TP Frye, AK George, A Kilchevsky, M Maruf, MM Siddiqui, M Kongnyuy, ... The Journal of urology 197 (3 Part 1), 640-646, 2017 | 104 | 2017 |
| Impact of Gleason subtype on prostate cancer detection using multiparametric magnetic resonance imaging: correlation with final histopathology M Truong, G Hollenberg, E Weinberg, EM Messing, H Miyamoto, TP Frye The Journal of urology 198 (2), 316-321, 2017 | 92 | 2017 |
| A comprehensive analysis of cribriform morphology on magnetic resonance imaging/ultrasound fusion biopsy correlated with radical prostatectomy specimens M Truong, C Feng, G Hollenberg, E Weinberg, EM Messing, H Miyamoto, ... The Journal of urology 199 (1), 106-113, 2018 | 89 | 2018 |
| Combined biparametric prostate magnetic resonance imaging and prostate-specific antigen in the detection of prostate cancer: a validation study in a biopsy-naive patient population M Fascelli, S Rais-Bahrami, S Sankineni, AM Brown, AK George, R Ho, ... Urology 88, 125-134, 2016 | 88 | 2016 |
| Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP) LE Johnson, TP Frye, AR Arnot, C Marquette, LA Couture, ... Vaccine 24 (3), 293-303, 2006 | 78 | 2006 |
| HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase BM Olson, TP Frye, LE Johnson, L Fong, KL Knutson, ML Disis, ... Cancer immunology, immunotherapy 59, 943-953, 2010 | 70 | 2010 |
| Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T cells LE Johnson, TP Frye, N Chinnasamy, D Chinnasamy, DG McNeel Cancer Immunology, Immunotherapy 56, 885-895, 2007 | 70 | 2007 |
| Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis M Kongnyuy, A Sidana, AK George, A Muthigi, A Iyer, R Ho, R Chelluri, ... Urologic Oncology: Seminars and Original Investigations 35 (1), 30. e1-30. e8, 2017 | 55 | 2017 |
| The role of MRI in active surveillance for prostate cancer M Fascelli, AK George, T Frye, B Turkbey, PL Choyke, PA Pinto Current urology reports 16, 1-8, 2015 | 53 | 2015 |
| Ocular radiation exposure in modern urological practice ER Taylor, B Kramer, TP Frye, S Wang, BF Schwartz, TS Köhler The Journal of urology 190 (1), 139-143, 2013 | 53 | 2013 |
| Multi‐institutional nomogram predicting benign prostate pathology on magnetic resonance/ultrasound fusion biopsy in men with a prior negative 12‐core systematic biopsy M Truong, B Wang, JB Gordetsky, JW Nix, TP Frye, EM Messing, ... Cancer 124 (2), 278-285, 2018 | 50 | 2018 |
| Incorporation and validation of clinically relevant performance metrics of simulation (CRPMS) into a novel full‐immersion simulation platform for nerve‐sparing robot‐assisted … MW Witthaus, S Farooq, R Melnyk, T Campbell, P Saba, E Mathews, ... BJU international 125 (2), 322-332, 2020 | 45 | 2020 |
| Preoperative multiparametric magnetic resonance imaging predicts biochemical recurrence in prostate cancer after radical prostatectomy R Ho, MM Siddiqui, AK George, T Frye, A Kilchevsky, M Fascelli, ... PLoS One 11 (6), e0157313, 2016 | 40 | 2016 |
| The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men M Kongnyuy, A Sidana, AK George, A Muthigi, A Iyer, M Fascelli, ... Urologic Oncology: Seminars and Original Investigations 34 (6), 254. e15-254 …, 2016 | 36 | 2016 |
| Historical and contemporary perspectives on cribriform morphology in prostate cancer M Truong, T Frye, E Messing, H Miyamoto Nature Reviews Urology 15 (8), 475-482, 2018 | 31 | 2018 |
| Multi‐institutional validation of a perfused robot‐assisted partial nephrectomy procedural simulation platform utilizing clinically relevant objective metrics of simulators (CROMS) A Ghazi, R Melnyk, AJ Hung, J Collins, A Ertefaie, P Saba, P Gurung, ... BJU international 127 (6), 645-653, 2021 | 30 | 2021 |
| Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers MJ Watson, AK George, M Maruf, TP Frye, A Muthigi, M Kongnyuy, ... Future Oncology 12 (21), 2417-2430, 2016 | 29 | 2016 |
| Impact of county rurality and urologist density on urological cancer mortality in Illinois TP Frye, DJ Sadowski, WE Zahnd, WD Jenkins, DI Dynda, GS Mueller, ... The Journal of urology 193 (5), 1608-1614, 2015 | 29 | 2015 |
| Application of IRIS three-dimensional anatomical models as preoperative surgical planning tools in the management of localized renal masses PMS Gurung, R Melnyk, T Holler, D Oppenhimer, M Witthaus, HH Rashid, ... Journal of Endourology 35 (3), 383-389, 2021 | 22 | 2021 |
Matthew Truong, M.D.Cleveland Clinic在 ccf.org 的电子邮件经过验证
Matthew Truong, M.D.Cleveland Clinic在 ccf.org 的电子邮件经过验证
Mohummad Minhaj SiddiquiProfessor, University of Maryland在 post.harvard.edu 的电子邮件经过验证